Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways - Wikidata - awgldk - TriplyDB

Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways

Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways

http://www.wikidata.org/entity/Q34998025

about

New Insights for Oxidative Stress and Diabetes Mellitus Dominant negative Ras attenuates pathological ventricular remodeling in pressure overload cardiac hypertrophy Human resistin promotes neutrophil proinflammatory activation and neutrophil extracellular trap formation and increases severity of acute lung injury Targeted gene-silencing reveals the functional significance of myocardin signaling in the failing heart Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectives Taking aim at Alzheimer's disease through the mammalian target of rapamycin Genomic and metabolic disposition of non-obese type 2 diabetic rats to increased myocardial fatty acid metabolism Mechanical stress triggers cardiomyocyte autophagy through angiotensin II type 1 receptor-mediated p38MAP kinase independently of angiotensin II.EGCG Blocked Phenylephrin-Induced Hypertrophy in H9C2 Cardiomyocytes, by Activating AMPK-Dependent Pathway Mammalian target of rapamycin signaling in diabetic cardiovascular disease Diabetic cardiomyopathy: is resistin a culprit?The apoptotic volume decrease is an upstream event of MAP kinase activation during Staurosporine-induced apoptosis in HeLa cells.Sugar, sex, and TGF-β in diabetic nephropathy.Myocardial Mycn is essential for mouse ventricular wall morphogenesis.Central resistin overexposure induces insulin resistance through Toll-like receptor 4.Adipose tissue biology and cardiomyopathy: translational implications.Diabetic cardiomyopathy and metabolic remodeling of the heart.Role of PI3K-AKT-mTOR and Wnt Signaling Pathways in Transition of G1-S Phase of Cell Cycle in Cancer Cells.Variants of resistin gene and the risk of idiopathic dilated cardiomyopathy in Pakistan.Resistin-induced cardiomyocyte hypertrophy is inhibited by apelin through the inactivation of extracellular signal-regulated kinase signaling pathway in H9c2 embryonic rat cardiomyocytes.The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy.Reduced phosphorylation of brain insulin receptor substrate and Akt proteins in apolipoprotein-E4 targeted replacement mice.Adipokines and the cardiovascular system: mechanisms mediating health and disease.AMP-activated protein kinase regulation and biological actions in the heart.Molecular targets of current and prospective heart failure therapies.The role of resistin in inflammatory myopathies.Programming apoptosis and autophagy with novel approaches for diabetes mellitus.LKB1/AMPK pathway mediates resistin-induced cardiomyocyte hypertrophy in H9c2 embryonic rat cardiomyocytes.Branched-chain amino acids differently modulate catabolic and anabolic states in mammals: a pharmacological point of view.Targeting the energy guardian AMPK: another avenue for treating cardiomyopathy?Exploring the Crosstalk between Adipose Tissue and the Cardiovascular System.mTOR: Driving apoptosis and autophagy for neurocardiac complications of diabetes mellitus.Obesity-induced kidney injury is attenuated by amelioration of aberrant PHD2 activation in proximal tubules Differential patterns of replacement and reactive fibrosis in pressure and volume overload are related to the propensity for ischaemia and involve resistin.Maternal undernutrition around the time of conception and embryo number each impact on the abundance of key regulators of cardiac growth and metabolism in the fetal sheep heart.High leptin and resistin expression in chronic heart failure: adverse outcome in patients with dilated and inflammatory cardiomyopathy.MicroRNA-200c modulates DUSP-1 expression in diabetes-induced cardiac hypertrophy.A role for calcium in resistin transcriptional activation in diabetic hearts

P2860

Q28080679-B3418F01-EC9A-49B5-8EF5-8C6DADF71474 Q28266103-35DF89F6-1C24-464C-9D5C-B45D671BE006 Q33600997-F8ED5C82-9478-4BFC-AC93-24E490A2BD77 Q34058563-AF351579-0F46-4AE2-B88A-ECC468359DA7 Q34289211-C83CD503-3E8C-4C94-A42C-3C48A69638E8 Q34603651-128DFA60-420B-432F-B826-AF155E93ACBE Q35036458-1FEFCD33-9A4C-42AB-911B-694C17C94F7B Q35107771-4375C515-0B24-4718-B1B6-F8756DBC1D0B Q35578591-3D95A84C-7E81-4D03-88AF-7052596F764F Q36100715-696E473B-DBB2-4E2F-AEFB-830698BBA0BB Q36174452-F123679B-D1FD-4966-943A-57CB04089030 Q36197432-653648D3-2092-47DD-95B2-86C0B173E90B Q36234919-71F57487-C59D-4D06-BAB6-0FAD43506FEC Q36428295-A75B1F2E-C104-4D7C-A0F5-3755F8D8C08B Q36477225-3856F75A-58C8-49B1-BE01-F35E7374FD34 Q36496035-EDB40CAF-8B83-4590-A4F7-1DBD736DCA2A Q36672871-A2795991-7C79-42FB-8432-3745588C414E Q36760689-603B8D0A-7B93-47FA-97CB-867FCA94C6BB Q36801783-7C2A731B-1601-4562-B588-30FF6DD52D71 Q37287964-99AEF28E-6FC8-4DF8-A926-532E168484B5 Q37317831-B80B7557-D6E1-406D-A9F6-2F0C1B0B9E90 Q37489258-97DA8C9B-FD5F-4B33-8052-2BDF8DB3DED0 Q38014474-339D250C-E43B-4CD7-A12C-28867C2CF7F7 Q38039283-D7ECC093-1792-4D3F-BC3C-BCF534A75BD1 Q38076688-1F898C0F-9E69-4362-9EDD-58B2D32CC8FA Q38099557-4D54C300-9484-495C-9996-9E38282D2462 Q38367977-F96A9DCD-321E-4BEB-8DFA-FE41C88E04A1 Q38718930-8009A39C-6707-4AFF-A08B-B070EF661384 Q38957303-0117F6E2-5D89-4505-85C9-575622C3704E Q38999231-4A6EC9FA-C51E-4034-B0D5-4601F6FC2529 Q41686212-FBA1223C-0F4B-43CB-9BD5-2D3A4CECBADA Q42031136-968AF435-B3F2-4706-AD1C-7E689589632A Q42371719-8BA00102-C7FF-4247-94B6-DC72448599A3 Q43544082-BE52A708-2234-4AA2-BB13-C0BE3073EB47 Q46793766-EF9909C4-D40E-44FE-8767-CF5352DA6C90 Q51347080-05956B89-750A-4F5F-990D-30A9F854AF1B Q51438500-10F2B066-3279-4E63-AC84-25F0C6EB6B72 Q57799740-045864A3-48BF-4EA1-BCE8-BE60463544FE

P2860

Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways

http://www.wikidata.org/entity/Q34998025

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Resistin promotes cardiac hype ...... ubstrate 1 (JNK/IRS1) pathways

@ast

Resistin promotes cardiac hype ...... ubstrate 1 (JNK/IRS1) pathways

@en

Resistin promotes cardiac hype ...... /mammalian target of rapamycin

@nl

type

label

Resistin promotes cardiac hype ...... ubstrate 1 (JNK/IRS1) pathways

@ast

Resistin promotes cardiac hype ...... ubstrate 1 (JNK/IRS1) pathways

@en

Resistin promotes cardiac hype ...... /mammalian target of rapamycin

@nl

prefLabel

Resistin promotes cardiac hype ...... ubstrate 1 (JNK/IRS1) pathways

@ast

Resistin promotes cardiac hype ...... ubstrate 1 (JNK/IRS1) pathways

@en

Resistin promotes cardiac hype ...... /mammalian target of rapamycin

@nl

P1433

Q34998025-402CC0D2-1AE9-44F7-A2D2-A125E0B3476F

P1476

Q34998025-7802229E-D7AB-4906-99DD-C7A63F93D349

P2093

Q34998025-315C3D30-14F6-456E-A887-DCDDA5328202

Q34998025-96AEC99E-2C10-4B6A-B0BE-A6191E30B853

Q34998025-BADC7F68-4E1A-4B05-BB78-EF901D8DB515

Q34998025-F88E6C72-26FF-4482-95A1-E5426A4A536F

P2860

Q34998025-0132C396-B0D4-4E31-A676-D86F84E84B71

Q34998025-09FA4327-84E0-4AC8-8A7C-35510DBF9F21

Q34998025-0A615711-27E8-45C5-A7FB-29880C1B89CD

Q34998025-1D45B57A-EE21-4A45-951D-C16FC7997DB8

Q34998025-1F476FB8-D7C5-456D-BC34-F5F6E26EE0C9

Q34998025-1F7B26D0-ED73-4B5F-BE6A-B68A0681FD4C

Q34998025-1FE47EBE-0CC7-41CF-97F4-62E143875514

Q34998025-215A017C-973D-4A78-9B3C-F1B447EB671A

Q34998025-24B552FB-F19F-450C-9AE0-A5CC089E879A

Q34998025-2B120E1D-5C35-4E1B-A933-55041BA0F308

P304

Q34998025-8385F372-0422-4BB8-9B83-B8A64585923B

P31

Q34998025-B2BDE201-8D72-40C0-AEE7-E5C60324FFBB

P356

Q34998025-DD86B8B9-61A2-42C6-B528-153C819686C7

P407

Q34998025-F2C6FE54-0143-481A-98F2-E39135934F63

P433

Q34998025-8BF4078D-6377-425A-BEA5-A452D7EF0978

P478

Q34998025-BF9377E1-A160-4099-9EC1-1DE1BDE8B0BA

P577

Q34998025-4A7CE41C-EB9C-48F4-81CC-04189D8527FF

P698

Q34998025-841EBFD7-6882-4011-B3C1-DB158B77C4B8

P932

Q34998025-234A7385-8228-4BF6-98D6-1DEFA20D2DA0

P356

JBC.M110.200022

P1433

Journal of Biological Chemistry

P1476

Resistin promotes cardiac hype ...... ubstrate 1 (JNK/IRS1) pathways

@en

P2093

Djamel Lebeche

http://www.w3.org/2001/XMLSchema#string

Elie R Chemaly

http://www.w3.org/2001/XMLSchema#string

Roger J Hajjar

http://www.w3.org/2001/XMLSchema#string

Soojeong Kang

http://www.w3.org/2001/XMLSchema#string

P2860

Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation

TSC2 mediates cellular energy response to control cell growth and survival

Immunopurified mammalian target of rapamycin phosphorylates and activates p70 S6 kinase alpha in vitro

The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307)

Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action

Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways

Expression of an active LKB1 complex in cardiac myocytes results in decreased protein synthesis associated with phenylephrine-induced hypertrophy

Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity

Cardiac hypertrophy: the good, the bad, and the ugly

The hormone resistin links obesity to diabetes

P304

18465-18473

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M110.200022

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

286

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21478152

http://www.w3.org/2001/XMLSchema#string

P932

3099663

http://www.w3.org/2001/XMLSchema#string